These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8747109)

  • 41. Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.
    Cooper EH; Forbes MA; Crockson RA; MacLennan IC
    J Clin Pathol; 1984 Aug; 37(8):852-8. PubMed ID: 6206095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment.
    Chen YT
    Pediatr Nephrol; 1991 Jan; 5(1):71-6. PubMed ID: 2025544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tubular dysfunction in extremely low birth weight survivors.
    Matsumura K; Matsuzaki Y; Hida M; Ikeda K; Awazu M
    Clin Exp Nephrol; 2019 Mar; 23(3):395-401. PubMed ID: 30238383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of living donor liver transplantation for glycogen storage disorders in children.
    Iyer SG; Chen CL; Wang CC; Wang SH; Concejero AM; Liu YW; Yang CH; Yong CC; Jawan B; Cheng YF; Eng HL
    Liver Transpl; 2007 Jun; 13(6):848-52. PubMed ID: 17539004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis.
    Glass S; Plant ND; Spencer DA
    J Cyst Fibros; 2005 Dec; 4(4):221-5. PubMed ID: 16239129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition.
    Martens DH; Rake JP; Navis G; Fidler V; van Dael CM; Smit GP
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1741-6. PubMed ID: 19808227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary lactate excretion in type 1 glycogenosis--a marker of metabolic control or renal tubular dysfunction?
    Lee PJ; Chatterton C; Leonard JV
    J Inherit Metab Dis; 1996; 19(2):201-4. PubMed ID: 8739965
    [No Abstract]   [Full Text] [Related]  

  • 48. Tubular damage in microalbuminuric patients with primary glomerulonephritis and diabetic nephropathy.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Ren Fail; 1995 Jan; 17(1):43-9. PubMed ID: 7770643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus.
    Rowe DJ; Anthony F; Polak A; Shaw K; Ward CD; Watts GF
    Ann Clin Biochem; 1987 Sep; 24 ( Pt 5)():477-82. PubMed ID: 3662397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary excretion of proteins and tubular enzymes in renal transplant patients.
    Donadio C; Puccini R; Lucchesi A; Giordani R; Rizzo G
    Ren Fail; 1998 Sep; 20(5):707-15. PubMed ID: 9768439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic glycogen storage disorders: what have we learned in recent years?
    Burda P; Hochuli M
    Curr Opin Clin Nutr Metab Care; 2015 Jul; 18(4):415-21. PubMed ID: 26001652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteinuria and other renal functions in Wilson's disease.
    Sözeri E; Feist D; Ruder H; Schärer K
    Pediatr Nephrol; 1997 Jun; 11(3):307-11. PubMed ID: 9203178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2
    Gibson RA; Lim JA; Choi SJ; Flores L; Clinton L; Bali D; Young S; Asokan A; Sun B; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):269-276. PubMed ID: 34083142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary excretion of N-acetyl-beta-D-glucosaminidase in children with type I diabetes mellitus.
    Ellis EN; Brouhard BH; Lagrone L; Travis LB
    Diabetes Care; 1983; 6(3):251-5. PubMed ID: 6347577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease.
    Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C
    Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal glomerular and tubular impairment during strenuous exercise in young women.
    Poortmans JR; Vancalck B
    Eur J Clin Invest; 1978 Jun; 8(3):175-8. PubMed ID: 99313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum lipoproteins of patients with glycogen storage disease.
    Rosenfeld EL; Chibisov IV; Karmansky IM; Tabolin VA; Chistova LV; Leontiev AF
    Clin Chim Acta; 1980 Mar; 102(1):99-104. PubMed ID: 6930334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.
    Ikarashi Y; Kakihara T; Imai C; Tanaka A; Watanabe A; Uchiyama M
    Pediatr Int; 2004 Oct; 46(5):570-5. PubMed ID: 15491386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical outcome of renal tubular damage in chronic heart failure.
    Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
    Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.